| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Physiology and Biophysics and Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505
Normal pregnancy is associated
with reductions in total vascular resistance and arterial pressure
possibly due to enhanced endothelium-dependent vascular relaxation and
decreased vascular reactivity to vasoconstrictor agonists. These
beneficial hemodynamic and vascular changes do not occur in women who
develop preeclampsia; instead, severe increases in vascular resistance
and arterial pressure are observed. Although preeclampsia represents a
major cause of maternal and fetal morbidity and mortality, the vascular and cellular mechanisms underlying this disorder have not been clearly
identified. Studies in hypertensive pregnant women and experimental
animal models suggested that reduction in uteroplacental perfusion
pressure and the ensuing placental ischemia/hypoxia during late
pregnancy may trigger the release of placental factors that initiate a
cascade of cellular and molecular events leading to endothelial and
vascular smooth muscle cell dysfunction and thereby increased vascular
resistance and arterial pressure. The reduction in uterine perfusion
pressure and the ensuing placental ischemia are possibly caused
by inadequate cytotrophoblast invasion of the uterine spiral arteries.
Placental ischemia may promote the release of a variety of
biologically active factors, including cytokines such as tumor necrosis
factor-
and reactive oxygen species. Threshold increases in the
plasma levels of placental factors may lead to endothelial cell
dysfunction, alterations in the release of vasodilator substances such
as nitric oxide (NO), prostacyclin (PGI2), and
endothelium-derived hyperpolarizing factor, and thereby reductions of
the NO-cGMP, PGI2-cAMP, and hyperpolarizing factor vascular
relaxation pathways. The placental factors may also increase the
release of or the vascular reactivity to endothelium-derived
contracting factors such as endothelin, thromboxane, and ANG II. These
contracting factors could increase intracellular Ca2+
concentrations ([Ca2+]i) and stimulate
Ca2+-dependent contraction pathways in vascular smooth
muscle. The contracting factors could also increase the activity of
vascular protein kinases such as protein kinase C, leading to increased myofilament force sensitivity to [Ca2+]i and
enhancement of smooth muscle contraction. The decreased endothelium-dependent mechanisms of vascular relaxation and the enhanced mechanisms of vascular smooth muscle contraction represent plausible causes of the increased vascular resistance and arterial pressure associated with preeclampsia.
endothelium; vascular smooth muscle; pregnancy; hypertension
This article has been cited by other articles:
|
|
 |
|
  K. J. Gibson, A. C. Boyce, C. L. Thomson, S. Chinchen, and E. R. Lumbers Interactions between subtotal nephrectomy and salt: effects on blood pressure and renal function in pregnant and nonpregnant ewes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1227 - R1233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Lu, H. Zhang, N. Gokina, M. Mandala, O. Sato, M. Ikebe, G. Osol, and S. A. Fisher Uterine artery myosin phosphatase isoform switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy Am J Physiol Cell Physiol, February 1, 2008; 294(2): C564 - C571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Gilbert, S. A. Babcock, and J. P. Granger Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression Hypertension, December 1, 2007; 50(6): 1142 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tesse, F. Meziani, E. David, N. Carusio, H. Kremer, F. Schneider, and R. Andriantsitohaina Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H520 - H525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Eghtesady, J. A. Sedgwick, J. L. Schenbeck, C. Lam, J. Lombardi, R. Ferguson, A. Gardner, J. McNamara, and P. Manning Maternal-Fetal Interactions in Fetal Cardiac Surgery Ann. Thorac. Surg., January 1, 2006; 81(1): 249 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Kaaja and I. A. Greer Manifestations of Chronic Disease During Pregnancy JAMA, December 7, 2005; 294(21): 2751 - 2757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Huang, Y. Zhou, V. T. Raju, J. Du, H.-H. Chang, C.-Y. Wang, M. W. Brands, J. R. Falck, and M.-H. Wang Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1116 - F1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Longo, V. Jain, Y. P. Vedernikov, R. Bukowski, R. E. Garfield, G. D. Hankins, G. D. Anderson, and G. R. Saade Fetal origins of adult vascular dysfunction in mice lacking endothelial nitric oxide synthase Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1114 - R1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Vila and M. Salaices Cytokines and vascular reactivity in resistance arteries Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1016 - H1021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhou, H.-H. Chang, J. Du, C.-Y. Wang, Z. Dong, and M.-H. Wang Renal epoxyeicosatrienoic acid synthesis during pregnancy Am J Physiol Renal Physiol, January 1, 2005; 288(1): F221 - F226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Thompson, K. Aguan, and H. Zhou Chronic Hypoxia Inhibits Contraction of Fetal Arteries by Increased Endothelium-Derived Nitric Oxide and Prostaglandin Synthesis Reproductive Sciences, December 1, 2004; 11(8): 511 - 520. [Abstract] [PDF]
|
|
|
|
|
|
L. Luksha, H. Nisell, and K. Kublickiene The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1102 - R1109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Payne, B. T. Alexander, and R. A. Khalil Decreased Endothelium-Dependent NO-cGMP Vascular Relaxation and Hypertension in Growth-Restricted Rats on a High-Salt Diet Hypertension, February 1, 2004; 43(2): 420 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Payne, B. T. Alexander, and R. A. Khalil Reduced Endothelial Vascular Relaxation in Growth-Restricted Offspring of Pregnant Rats With Reduced Uterine Perfusion Hypertension, October 1, 2003; 42(4): 768 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Scholz Prostaglandins Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R512 - R514. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Granger Endothelin Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R298 - R301. [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, H.-D. Je, S. Malek, and K. G. Morgan ERK1/2-mediated phosphorylation of myometrial caldesmon during pregnancy and labor Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R192 - R199. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
